Novanta Inc.
Financials
Valuation Metrics
Novanta Inc.'s Market Cap is $5.53B. At end of 2025 it was $4.55B. Ranked #1266 of 3,118 in US market (top 41%), #419 of 1,474 on NASDAQ (top 28%), #51 of 99 in Technology Hardware & Equipment (top 52%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $5.53B | US#1,266/3,118 Sec#51/99 |
| Revenue | $1.03B | US#1,849/3,118 Sec#63/99 |
| Net Income | $62M | US#1,790/3,118 Sec#57/99 |
| Total Assets | $2.14B | US#2,029/3,118 Sec#60/99 |
| Net Assets | $1.62B | US#1,398/3,118 Sec#48/99 |
| Employees | 3,000 | US#1,468/3,118 Sec#58/99 |
| Value | ||
| P/E | 89.56x | US#2,070/3,118 Sec#68/99 |
| P/B | 3.42x | US#1,909/3,118 Sec#43/99 |
| PEG | 136.36x | US#1,291/3,118 Sec#53/99 |
| P/S | 5.37x | US#2,355/3,118 Sec#67/99 |
| EV/EBITDA | 36.50x | US#2,287/3,118 Sec#76/99 |
| FCF Yield | 2.07% | US#2,013/3,118 Sec#62/99 |
| Profitability | ||
| ROE | 3.82% | US#1,890/3,118 Sec#64/99 |
| ROA | 2.89% | US#1,430/3,118 Sec#61/99 |
| Op. Margin | 10.43% | US#1,538/3,118 Sec#43/99 |
| Revenue Growth | 7.61% | US#1,490/3,118 Sec#65/99 |
| Earnings Growth | 0.66% | US#1,278/3,118 Sec#53/99 |
| Financial Health | ||
| Debt Ratio | 32.36% | US#365/3,118 Sec#15/99 |
| Total Debt | $283M | US#2,107/3,118 Sec#49/99 |
| FCF | $114M | US#1,672/3,118 Sec#53/99 |
| Cash | $719M | US#854/3,118 Sec#35/99 |
| Current Ratio | 4.57x | US#513/3,118 Sec#14/99 |
| Net Debt/EBITDA | -3.12x | US#112/3,118 Sec#3/99 |
| Performance | ||
| 1Y Return | 15.16% | US#1,265/3,118 Sec#51/99 |
| 1M Return | -2.01% | US#1,530/3,118 Sec#23/99 |
| From 52W High | -17.07% | US#1,331/3,118 Sec#24/99 |
| 1Y MDD | -26.97% | US#1,073/3,118 Sec#22/99 |
| Trading | ||
| Volume | 299,960 shares | US#2,442/3,118 Sec#84/99 |
| Trading Value | $44M | US#1,444/3,118 Sec#64/99 |
| Per Share | ||
| EPS | $1.63 | US#1,461/3,118 Sec#52/99 |
| BPS | $42.74 | US#559/3,118 Sec#23/99 |
Company Info
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.